Epidemiologic and Clinical Characteristics of Guillain-Barré Syndrome in Patients Referred to Sina Hospital in Hamadan in 2018
Epidemiology and Health System Journal · 2022
DOI: 10.34172/ehsj.2022.27 ↗At a glance
Journal article in Epidemiology and Health System Journal, 2022. Written by Mojtaba Khazaei and 4 co-authors. Cited 1 times so far (Crossref).
Abstract (original language)
Background and aims: Guillain-Barré syndrome (GBS) has several types, some of which damage myelin and some others cause axonal damage. Detecting the type of GBS is important in determining the type of treatment and its prognosis. This study was conducted to investigate the epidemiological characteristics of GBS and its variants in patients referred to Sina hospital in Hamadan, Iran, in 2018. Methods: In this cross-sectional study, 51 patients who were admitted to Sina hospital and diagnosed with GBS in 2018 were examined. Demographic data, GBS type, disease outcomes, and pre-clinical and clinical findings of patients were collected. Data were then analyzed using the Stata software version 12, and P value
Cite
APA
Khazaei, M., Ghasemi, F., Mazdeh, M., Khanlarzadeh, E., & Ghiasian, M. (2022). Epidemiologic and Clinical Characteristics of Guillain-Barré Syndrome in Patients Referred to Sina Hospital in Hamadan in 2018. Epidemiology and Health System Journal. https://doi.org/10.34172/ehsj.2022.27
Vancouver
Khazaei M, Ghasemi F, Mazdeh M, Khanlarzadeh E, Ghiasian M. Epidemiologic and Clinical Characteristics of Guillain-Barré Syndrome in Patients Referred to Sina Hospital in Hamadan in 2018. Epidemiology and Health System Journal. 2022. doi:10.34172/ehsj.2022.27
BibTeX
@article{Khazaei2022,
author = {Khazaei, Mojtaba and Ghasemi, Fatemeh and Mazdeh, Mehrdokht and Khanlarzadeh, Elham and Ghiasian, Masoud},
title = {Epidemiologic and Clinical Characteristics of Guillain-Barré Syndrome in Patients Referred to Sina Hospital in Hamadan in 2018},
journal = {Epidemiology and Health System Journal},
year = {2022},
doi = {10.34172/ehsj.2022.27}
}
EUVIMED